Publication | Open Access
FGFR3 signaling and function in triple negative breast cancer
72
Citations
41
References
2020
Year
These results indicate that targeting FGFR3 may represent a therapeutic option for TNBC, but only for patients with oncogenic FGFR3 alterations, such as the FGFR3-TACC3 fusion. Video abstract.
| Year | Citations | |
|---|---|---|
Page 1
Page 1